Article Details

HanAll Biopharma Secures Japan's Orphan Drug Status For Batoclimab In Thyroid Eye Disease

Retrieved on: 2025-03-06 22:36:13

Tags for this article:

Click the tags to see associated articles and topics

HanAll Biopharma Secures Japan's Orphan Drug Status For Batoclimab In Thyroid Eye Disease. View article details on hiswai:

Excerpt

HanAll Biopharma (009420.KS) Thursday announced that Batoclimab, its anti-FcRn therapy for autoimmune diseases, has received Orphan Drug ...

Article found on: www.rttnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo